Patient on intravenous therapy

Help reduce the risk of bloodstream infections at all access points.


Often the first entry into a patient’s body, intravenous therapy remains a common and critical intervention, but it is not without risks. Catheter-associated bloodstream infections (CABSIs) can be acquired at the time of the initial insertion or anytime throughout the duration of venous access — creating the potential for longer hospital stays, increased care costs and higher patient mortality. Incorporating evidence-based standards to IV insertion, care and maintenance can help protect against the factors that may lead to increased risk of bloodstream infection.

  • Icon of I.V with green and blue background

    60% of all CABSIs originate from some form of vascular access.¹

  • Icon of human figures with green and blue background

    1 in 4 patients who contract a CABSI will die.²

  • Icon of stack of money with green and blue background

    The cost to treat one CABSI averaged $45,000 USD per patient.³,⁴

Healthcare professional setting out catheter parts on a table

Best practices for preventing infection in clinical settings.

The Infusion Nurses Society (INS) is a global authority on infusion therapy, setting stringent standards for practice. Every five years, INS releases updated, peer-reviewed standards that reflect the latest evidence to define and develop best practices for all clinical settings. 3M can help you stay up to date so you can help deliver better patient outcomes.

We can help you meet current guidelines with evidence-based solutions.

Protecting patients from CABSIs requires a commitment from the care team to methodically adhere to evidence-based standards established by well-regarded organizations such as INS, SHEA, APIC and CDC.

3M partners with you, offering a portfolio of innovative solutions to help you protect every IV catheter site — from insertion to removal — every time. From hand hygiene and barrier films to securement devices, disinfecting caps and more, our evidence-based products help you deliver compassionate care, protect patients, help prevent the risks of costly complications, and improve patient satisfaction.

Need more information? Connect with 3M.
Health Care Professional in ICU with a patient

Comprehensive Infection Prevention

3M takes a holistic approach to help you identify and reduce infection and transmission risks, navigate rapidly changing standards and guidelines, and provide science-based solutions that can help you protect patients, staff and everyone who enters your facility.


3M resources to help you stay informed.

  • Thank you for your interest in 3M! Please fill in the form and hit the “Connect” button. Fields marked with * are mandatory.

  • Which 3M IV Care products are you interested in?

  • (Hold [Ctrl] key to select multiple options)

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Connect

Thank You

Thank you for connecting with 3M! We’ll be in touch with you shortly.

Our Apologies...

An error has occurred while submitting. Please try again later...

  • 1. Maki D, Mermel L: Infections due to infusion therapy. In Hospital Infections, edn 4.Edited by Bennett JV, Brachman PS. Philadelphia: Lippincott-Raven; 1998:689–724.
  • 2. CDC Vital Signs: Making health care safer: Reducing bloodstream infections. Centers for Disease Control and Prevention website. Published March, 2011. Accessed June 18, 2017.
  • 3. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005 Dec 1;41(11):1591-1598
  • 4. Zimlichman E, Henderson D, et al. Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System. JAMA Intern Med. 2013 Dec 9-23;173(22):2039-2046. doi: 10.1001/ jamainternmed.2013.9763
  • 5. Gorski, L. A., Hadaway, L., Hagle, M.E., Broadhurst, D., Clare, S., Kleidon, T., Meyer, B.M., Nickel, B., Rowley, S., Sharpe, E., Alexander, M. (2021). Journal of Infusion Nursing, 44(suppl 1):S1-S224. doi:10.1097/NAN.0000000000000396. Refer to the document to view verbatim, comprehensive standards and practice recommendations.
  • 6. 3M data on file: EM-05-014359.
  • 7. George M, Ujwala P, Guduri, V, & Smith G. Use of a barrier film (3M™ Cavilon™ No Sting Barrier Film) to reduce local skin complications around peripherally inserted central catheter lines: A randomised prospective controlled study. WCET Journal. 2016; 8-13.
  • 8. Pivkina AI, Gusarov VG, Blot SI, Zhivotneva IV, Pasko NV, Zamyatin MN. Effect of an acrylic terpolymer barrier film beneath transparent catheter dressings on skin integrity, risk of dressing disruption, catheter colonisation and infection. Intensive Crit Care Nurs. 2018; 46: 17-23.
  • 9. Chen Y-H, Hsieh H-L, Shih W-M. Applying skin barrier film for skin tear management in patients with central venous catheterization. Adv Skin Wound Care. 2020; 33: 582-586.
  • 10. Campbell K, Woodbury MG, Whittle H, Labate T, Hoskin A. A clinical evaluation of 3M™ Cavilon™ No Sting Barrier Film. Ostomy Wound Management.2000;46(1):24-30.